Capillary Blood Is a Viable Option for Routine Testing
Babson Diagnostics has validated capillary blood as a reliable alternative to venous blood for routine diagnostic testing.
Read MorePosted by Chris Wolski | May 19, 2025 | Specimen Collection & Handling |
Babson Diagnostics has validated capillary blood as a reliable alternative to venous blood for routine diagnostic testing.
Read MorePosted by Chris Wolski | Apr 8, 2025 | Company News |
NeoGenomics has acquired Pathline, LLC to strengthen its presence in the Northeast U.S. and accelerate growth in oncology testing services.
Read MorePosted by Chris Wolski | Apr 4, 2025 | Hematology & Serology |
Babson Diagnostics has expanded its BetterWay blood testing menu to 61 tests, including key thyroid, kidney & cardiovascular health markers.
Read MorePosted by Chris Wolski | Mar 31, 2025 | Centrifuges |
Thermo Fisher Scientific has launched new floor-model centrifuges featuring GreenCool Technology, providing sustainable solutions for labs.
Read MorePosted by Chris Wolski | Mar 11, 2025 | Company News |
NeoGenomics, Inc. has acquired Pathliine, expanding its oncology testing services and accelerating growth in other testing.
Read More